Compass Therapeutics Inc (CMPX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Sales | 0 | 0 | 850 | 0 | 0 |
| Gross Profit | N/A | N/A | 850 | N/A | N/A |
| Operating Expenses | 16,571 | 12,239 | 15,895 | 12,770 | 15,389 |
| Operating Income | -16,571 | -12,239 | -15,045 | -12,770 | -15,389 |
| Other Income | 1,540 | 1,758 | 1,969 | 1,983 | 1,974 |
| Pre-tax Income | -15,031 | -10,481 | -13,076 | -10,787 | -13,415 |
| Net Income Continuous | -15,031 | -10,481 | -13,076 | -10,787 | -13,415 |
| Net Income | $-15,031 | $-10,481 | $-13,076 | $-10,787 | $-13,415 |
| EPS Basic Total Ops | -0.10 | -0.08 | -0.10 | -0.08 | -0.10 |
| EPS Basic Continuous Ops | -0.11 | -0.08 | -0.10 | -0.08 | -0.11 |
| EPS Diluted Total Ops | -0.10 | -0.08 | -0.10 | -0.08 | -0.10 |
| EPS Diluted Continuous Ops | -0.11 | -0.08 | -0.10 | -0.08 | -0.11 |
| EPS Diluted Before Non-Recurring Items | -0.11 | -0.08 | -0.10 | N/A | N/A |
| EBITDA(a) | $-16,482 | $-12,052 | $-15,306 | $-12,683 | $-15,733 |